Anzeige
Mehr »
Login
Freitag, 10.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
100 % Anstieg in zwei Tagen: Das technische Signal, das Wall Streets Bären in Panik versetzt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
739 Leser
Artikel bewerten:
(2)

Tata Elxsi and Syntiant to Provide Low-Power Edge AI Device Development for Voice Applications

Finanznachrichten News

BANGALORE, India, Jan. 26, 2021 /PRNewswire/ -- Tata Elxsi and Syntiant Corp., a deep learning chip technology company, today announced a collaboration to help manufacturers design and develop low-power always-on voice applications across multiple product categories, such as smart home devices and consumer electronics, as well as industrial and automotive use cases.

Tata_Elxsi_Logo

The agreement between Tata Elxsi and Syntiant aims to provide end-to-end solutions and services for customers using Syntiant's deep learning Neural Decision Processors to enable low-power AI optimization in edge devices easily. The companies can deliver a turnkey solution that brings low latency, highly accurate inference to near- and far-field voice applications, including speaker identification, keyword spotting, multiple wake words, event detection, and local commands recognition.

Speaking about this partnershipNitin Pai, Chief Marketing and Strategy Officer, Tata Elxsi, said, "Tata Elxsi with its Artificial Intelligence Centre of Excellence addresses the growing needs of intelligent systems. We work on various AI and machine learning areas. The problem statement varies from use-case where AI can enhance everyday life quality through intelligent smart appliances to enable predictive analysis, anomaly detection in a factory environment, and advanced autonomous driving. By intersecting design thinking with advanced technologies, we help our clients bring innovative AI-enabled edge devices to the global market using Syntiant AI processors."

"Syntiant is in the business of deep learning and semiconductor design to advance machine learning capabilities in edge devices. Our neural decision processors provide superior performance at a fraction of the power of any DSP on the market today. We're collaborating with Tata Elxsi to combine our resources and make it easy for customers to embed AI in almost any smart device, from wearables to TV and key fob remotes to set-top boxes and beyond, with minimal or no drain on battery power consumption, " said Mallik Moturi, Vice President of product and business development at Syntiant

The Syntiant NDP120 is the company's latest generation of special-purpose chips for audio and sensor processing, which can run multiple applications simultaneously at under 1mW, including echo-cancellation, beamforming, and noise suppressions, multi-modal sensor fusion, infrared detection, and multi-axis acceleration, among others.

Tata Elxsi and Syntiant will host a free webinar on Wednesday, January 27 at 4 p.m. GMT/8 a.m. PST titled, "Lowest Power TinyML Solutions for Edge Devices in Voice, Audio and Sensor Apps."

Executives from both companies will explore new TinyML solutions for smart devices through DNN-enabled AI processors, along with interesting case studies across smart homes and other consumer applications.

Those who are interested to attend the webinar can click here to register.

About Syntiant

Founded in 2017 and headquartered in Irvine, Calif., Syntiant Corp. is moving artificial intelligence and machine learning from the cloud to edge devices. Syntiant's advanced chip solutions merge deep learning with semiconductor design to produce ultra-low-power, high performance, deep neural network processors for always-on applications in battery-powered devices, such as smartphones, smart speakers, earbuds, hearing aids, and laptops. The company is backed by several of the world's leading strategic and financial investors, including Intel Capital, Microsoft's M12, Applied Ventures, Robert Bosch Venture Capital, the Amazon Alexa Fund, and Atlantic Bridge Capital. Syntiant continues to be recognized as an industry leader, being named to Gartner's April 2020 Cool Vendors in AI Semiconductors; Fast Company's prestigious list of the World's Most Innovative Companies for 2020; as well as a CES 2021 Innovation Awards Honoree and CES 2020 Best of Innovation Awards Honoree. More information on the company can be found by visiting www.syntiant.com or by following Syntiant on Twitter @Syntiantcorp.

About Tata Elxsi (www.tataelxsi.com)

Tata Elxsi is amongst the world's leading providers of design and technology services across industries, including Automotive, Broadcast, Communications, Smart Home, Healthcare, and Transportation.

Tata Elxsi helps customers reimagine their products and services through design thinking and the application of digital technologies such as IoT (Internet of Things), Cloud, Mobility, Virtual Reality, and Artificial Intelligence.

Our multi-domain expertise amassed over decades enables our AI services to empower customers to drive innovation for next-gen products and integrate with other advanced technologies such as IoT and Intelligent Automation, to solve pivotal challenges in the AI transformation journey.

Media Contacts:

Tata Elxsi
Hari Balan
Corporate Communication
+91-80-2297-9123
Email: media@tataelxsi.com

Syntiant Corp.
George Medici
PondelWilkinson Inc.
+1-310-279-5968
Email: gmedici@pondel.com

© 2021 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.